Instructions to authors
Vasa

Hogrefe AG
Länggass-Strasse 76
3012 Bern
Switzerland

Tel. +41 31 300 45 00
Fax +41 31 300 45 90
zeitschriften@hogrefe.chwww.hogrefe.ch

02 INSTRUCTIONS TO AUTHORS

Vasa – European Journal of Vascular Medicine – publishes original research articles, case reports and reviews on vascularbiology, epidemiology, prevention, diagnosis, medical treatment and interventions for diseases of the arterial circulation, in thefield of phlebology and lymphology including the microcirculation, except the cardiac circulation. All papers must not have been
published elsewhere nor be under consideration for publication elsewhere. All original papers, reviews, and letters to the editor
must be in English. Acceptance of the paper by editors automatically transfers the copyright to the publishers in accordancewith existing copyright laws.

Publication ethics
It is important to the Hogrefe Publishing Group that our scientific journals and all the people involved adhere to the highest
ethical standards. Please take a moment to review our guidelines on what this means for authors, editors, reviewers, andus as a publisher.
More information: https://www.hogrefe.com/eu/service/forjournal-authors/publication-ethics

Preparation of themanuscript

Summary
The summary should contain a maximum of 300 words. For
original contributions, it should be structured (Background,Patients and methods, Results, Conclusions).
Main body
There is a maximum of 12 authors. The first given names arewritten out in full. Further co-workers like participating clinics
or board members are mentioned in the text before the references. The paper itself should be structured according to international standards and contain the following sections: Introduction, Material and methods or Patients and methods, Results,Discussion, Limitations, Conclusions, if necessary with subheadings. There are no colons in the title, but dashes.
Frequently used abbreviations should be written out upon
first mentioning, followed by the proper abbreviation inparentheses.

Ethics of investigation on human subjects: In manuscripts
describing research on humans, the authors should include
a statement that the protocol was reviewed and approved by
the appropriate ethical committee. Only systematic review articles will be considered. Reviews and meta-analyses shouldfollow the PRISMA Statement (http://www.prisma-statement.org/). Randomised trials should follow the CONSORT Statement (http://www.consort-statement.org/) and observational studies the STROBE Statement (https://www.strobe-statement.org/).

Word count
The total word count must be indicated in the main body document. Tables should be numbered sequentially in Romannumerals. Figures should be submitted in reproducible form
(unscreened originals, black-and-white glossies, laser printouts of graphs, slides) and numbered sequentially in Arabicnumbers. The figure legends should be added on a separate
sheet. The abbreviations in the tables and figures must all be
explained in the corresponding legend. There are colons as
equal signs and semicolons as separators, a point is set after
the legends. Only a total of 6 figures and tables are allowed,
these must also be mentioned in the text.

The Editorial Manager automatically creates a title page; hence, it does not need to be included. The maximum lenghth per
article in the different categories is defined as follows:

Electronic supplementary material

Editorial
max. 1,500 words and 15 references
Review
max. 7,000 words and 75 references
Original communications
max. 4,000 words and 30 references

Electronic supplementary material (ESM) may be submitted.
This material (further tables, figures, audio and video files, etc.)
will be published online only and with free access. The ESM
material has its own numbering, detached from the pictures inthe text. The last chapter of the text describes the ESM. Eachindividual material is explained there in one sentence.
Please ensure that any ESM submitted with the article are incompliance with the EU General Data Protection Regulation(GDPR).

Letter to the editor
max. 600 words and 5 references© 2024 Hogrefe

INSTRUCTIONS TO AUTHORS 03

References
The reference list is inserted into the manuscript document
and should correspond to the Vancouver style (see Examples).
References are numbered consecutively in the order in which
they are first mentioned. Each reference is listed once only,with the number in square brackets.
Only up to six authors of each reference can be listed, the rest
must be abbreviated by “et al.”. References in the text shouldbe put in square brackets, except when authors are mentioned for stylistic reasons. The journal names should be abbreviated in accordance with the List of Journals in the Index
Medicus. The DOI number appears only if the paper has not
yet been printed.

Editing andtranslation services
Hogrefe has negotiated a 20% discount for authors who wish
to have their manuscript professionally edited or translated
into English by the experts at Enago before submission. Please note that the service is independent of Hogrefe and use of
it has no bearing on acceptance decisions made by individualjournals.

Manuscript submission

Examples• Murphy MP, Lawson JH, Rapp BM, Dalsing MC, Klein J,Wilson MG, et al. Autologous bone marrow mononuclear
cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia. J Vasc Surg.
2011;53:1565–74.
• Wester T, Jorgensen JJ, Stranden E, Sandbaek G,
Tjonnfjord G, Bay D, et al. Treatment with autologous
bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study. Scand J Surg.
2008;97:56–62.
• Benoit E, O’Donnell TF, Iafrati MD, Asher E, Bandyk DF,Hallett JW, et al. The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design. J Transl Med.
2011;9:165.
• Barc P, Skora J, Pupka A, Turkiewicz D, Dorobisz AT,
Gargarek J, et al. Bone-marrow cells in therapy of critical limb ischemia of lower extremities – our own experience. Acta Angiologica. 2006;12:155–66.
The correspondence address must be entered directly into
the system (Editorial Manager) and encompass academic title and complete address, including international country abbreviation and e-mail address.
Body text, tables and references are to be entered only at theappropriate places in the EM, not at the same time as a complete manuscript in the body text.
The galley proof will shall be sent to the corresponding author.
Changes of content or style should be made only in exceptional cases. Correction costs exceeding 5 % of the typesetting
costs will be invoiced to the author(s).

© 2024 Hogrefe

Authors should submit the manuscript in electronic form to
http://www.editorialmanager.com/vasa. The online manuscript submission and review system for the journal offers
easy and straightforward log-in and submission procedures.
This system supports a wide range of submission file formats:for manuscripts – Word, WordPerfect, RTF, TXT, and LaTex; forfigures – TIFF, GIF, JPEG, EPS, PPT, and Postscript. Each pageof the manuscript should contain the page number in the upper right-hand corner. Please do not submit any hard copiesof the manuscript. Please note that your manuscript will not
be edited or corrected by the publisher, it will only be formallyand correctly implemented. Particular attention must be paidto linguistic correctness.
• When submitting a review article the journal prefersa systematic review rather than a narrative one.
Please ad here to the PRISMA guidelines(http://www.prisma-statement.org/).
• Editorials are only accepted by invitation.

Access to the article
With the first online publication of each accepted article thecorresponding author is granted access to the publisher's
version of the article with the possibility to download it (PDF).
This version is for personal use only, which includes the distribution to the co-authors.

04 INSTRUCTIONS TO AUTHORSCopyright
The author confirms and guarantees on behalf of themself
and any coauthors that they hold all copyrights to the submitted contribution, including any figures, photographs, line drawings, plants, maps, sketches, and tables, and that the article
and its contents do not infringe in any way on the rights ofthird parties. Upon acceptance of the article for publication,
the author agrees to transfer to the publisher the exclusive
right to reproduce and distribute the article and its contents,
both physically and in non-physical, electronic, or other form,in the journal to which it has been submitted and in other independent publications, with no limitations on the number ofcopies or on the form or the extent of distribution. These rights
are transferred for the duration of the copyright as defined by
Swiss law. Furthermore, the author transfers to the publisher
the following exclusive rights to the article and its contents:• The rights to produce advance copies, reprints or offprints of the article, in full or in part, to undertake orallow translations into other languages, to distributeother forms or modified versions of the article, and toproduce and distribute summaries or abstracts.
• The rights to microfilm and microfiche editions or similar,
the rights to use the article and its contents in videotext,
teletext, and similar systems, the right to record the con-tent or reproduce it to other, digital or analogue, including
electronic, magnetic, and optical media, and in multimedia form, as well as for public broadcasting in radio,television, or other forms of broadcasting. The rights tostore the article and its contents in machine-readable
or electronic form on all media (such as computer disks,
compact disks, magnetic tape), to store the article and its
contents in online databases belonging to the publisher
or to third parties for viewing or for downloading by third
parties, and to present or reproduce the article or its contents on visual display screens, monitors, and similar devices, either directly or via data transmission.
• The rights to reproduce and distribute the article and its
contents by all other means, including photomechanicaland similar processes (such as photocopying or facsimile), and as part of so-called document delivery services.
• The right to transfer any or all of the rights mentioned
in this agreement as well as the rights retained by theVerwertungsgesellschaft «WORT» including the corresponding royalty rights to third parties within or outsideof Switzerland.

Status: September 2024

© 2024 Hogrefe